Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,367,663
+$145,805 QoQ
Shares Held
5,435
-3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2,264
of 4,150 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Range Financial Group LLC holds $24,424,846 across 12 Drug Manufacturers - General names. ABBV ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,427 | $6,509,307 | |
| 2 | JNJ |
Johnson & Johnson
|
20,421 | $5,186,321 | |
| 3 | AMGN |
Amgen Inc
|
13,553 | $4,907,812 | |
| 4 | NVO |
Novo Nordisk A S
|
54,505 | $2,612,969 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
5,435 | $1,367,663 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,837 | $912,527 | |
| 7 | GSK |
GSK plc
|
16,868 | $884,220 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,073 | $523,380 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,367,663 | 5,435 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,221,858 | 5,618 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,079,843 | 4,726 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $3,896,586 | 16,829 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,779,102 | 14,972 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $3,053,334 | 14,573 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,628,893 | 14,794 | Shares | Sole | 2025-01-07 | |
| 2024-06-30 | $2,396,477 | 13,972 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,578,900 | 14,162 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,155,322 | 13,908 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,312,964 | 15,517 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,135,739 | 15,852 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $4,098,199 | 25,715 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $4,236,121 | 26,212 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $3,436,849 | 25,608 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $4,437,351 | 28,972 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $4,840,604 | 29,860 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $4,076,352 | 30,106 | Shares | Sole | 2022-07-11 | |
| 2021-09-30 | $3,208,701 | 29,746 | Shares | Sole | 2022-07-11 | |
| 2021-06-30 | $3,293,480 | 29,239 | Shares | Sole | 2022-07-11 | |
| 2021-03-31 | $2,955,163 | 27,307 | Shares | Sole | 2022-07-11 | |
| No filing history on record for this holder in this stock. | ||||||